| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Nuclear targeting signal recognition: a key control point in nuclear transport?
|
Bioessays
|
2000
|
3.17
|
|
2
|
Calcitonin receptor antibodies in the identification of osteoclasts.
|
Bone
|
1999
|
1.29
|
|
3
|
Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema.
|
Eur J Pharmacol
|
1986
|
1.24
|
|
4
|
Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
|
Proc Natl Acad Sci U S A
|
1985
|
1.24
|
|
5
|
PC8 [corrected], a new member of the convertase family.
|
Biochem J
|
1996
|
1.16
|
|
6
|
trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.
|
J Biol Chem
|
1985
|
1.14
|
|
7
|
Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
|
Lab Invest
|
1985
|
1.14
|
|
8
|
A randomised placebo-controlled trial of vaginal misoprostol for cervical priming before hysteroscopy in postmenopausal women.
|
BJOG
|
2002
|
1.11
|
|
9
|
Nuclear import of Creb and AP-1 transcription factors requires importin-beta 1 and Ran but is independent of importin-alpha.
|
Biochemistry
|
2001
|
1.02
|
|
10
|
Review of effects of water pollution on the breeding success of waterbirds, with particular reference to ardeids in Hong Kong.
|
Ecotoxicology
|
2001
|
1.02
|
|
11
|
Specific binding sites for platelet activating factor in human lung tissues.
|
Biochem Biophys Res Commun
|
1985
|
1.01
|
|
12
|
Ureaplasma urealyticum in patients with acute symptoms of urinary tract infection.
|
J Urol
|
1982
|
0.98
|
|
13
|
A fluorescent cholesterol analog traces cholesterol absorption in hamsters and is esterified in vivo and in vitro.
|
J Lipid Res
|
1999
|
0.96
|
|
14
|
Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes.
|
J Biol Chem
|
1986
|
0.94
|
|
15
|
Species difference in the specific receptors of platelet activating factor.
|
Biochem Pharmacol
|
1986
|
0.91
|
|
16
|
Adenomatous hyperplastic polyp of the gall bladder associated with cholelithiasis in a child.
|
Pediatr Surg Int
|
2003
|
0.86
|
|
17
|
Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
|
J Pharmacol Exp Ther
|
1988
|
0.85
|
|
18
|
Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
|
Mol Pharmacol
|
1989
|
0.83
|
|
19
|
Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor.
|
J Biol Chem
|
1986
|
0.82
|
|
20
|
Pitfalls of the application of microdialysis in clinical oncology: controversial findings with docetaxel.
|
J Pharm Biomed Anal
|
2007
|
0.80
|
|
21
|
Synthetic glycopeptide substrates for receptor-mediated endocytosis by macrophages.
|
Proc Natl Acad Sci U S A
|
1981
|
0.79
|
|
22
|
Determination of microcystins in cyanobacterial blooms by solid-phase microextraction-high-performance liquid chromatography.
|
Environ Toxicol Chem
|
2001
|
0.79
|
|
23
|
L-659,989: a useful probe in the detection of multiple conformational states of PAF receptors.
|
Lipids
|
1991
|
0.77
|
|
24
|
Effects of radiation therapy on vascular responsiveness.
|
J Cardiovasc Pharmacol
|
2001
|
0.76
|
|
25
|
The effects of endurance exercise on dystrophic mdx mice. II. Contractile properties of skinned muscle fibres.
|
Proc Biol Sci
|
1993
|
0.76
|
|
26
|
Comparative bioavailability study of two brands of prazosin-containing tablets in healthy volunteers.
|
Pharm Weekbl Sci
|
1990
|
0.75
|
|
27
|
The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
|
Int J Tissue React
|
1985
|
0.75
|
|
28
|
Determination of polychlorinated biphenyls in human blood serum by SPME.
|
Chemosphere
|
1999
|
0.75
|
|
29
|
MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
|
J Lipid Mediat
|
1993
|
0.75
|
|
30
|
Toxicology and evaluation of microcystins.
|
Ther Drug Monit
|
2000
|
0.75
|